Clinical Trial Update: GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab [Phase 2]

View source ↗

Summary

Phase 2 trial assessing GVAX Pancreas Vaccine (with Cyclophosphamide) and CRS-207 with or without nivolumab in previously treated metastatic pancreatic adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• CRS-207
• GVAX Pancreas Vaccine
• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Previously Treated Metastatic Adenocarcinoma of the Pancreas | Phase 2 | Status: COMPLETED | Results posted: 2019-10-08